Rising Diabetes, Cancer, Cardiovascular and Chronic Diseases to Boost Patient Registry Software Market to USD 1.5 Billion by 2020, Published by iHealthcareAnalyst, Inc.

Maryland Heights, MO, September 09, 2016 --(PR.com)-- The global patient registry software market is estimated to reach USD 1.5 Billion in 2020, growing at a CAGR of 8.4% from 2016 to 2020, according to a market research report Patient Registry Software Market, 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Patient Registry Software Market, 2013-2020 report at http://www.ihealthcareanalyst.com/report/patient-registry-software-market/

The global patient registry software market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

A patient registry database is created for the sole purpose of collecting secondary data related to patients, whereas patient registry software is a disease registry, medical registry, device registry - web-based, HIPAA compliant software.

Computerized disease registries in the context of health information exchange (HIE) provides disease and chronic care management services with the ability to effectively identify and manage patients with a particular condition across a region.

The global patient registry software market segmentation is based on disease types (cancer, cardiovascular, diabetes, rare or orphan disease), registry types (public and private domain), and end users (government and private). The global patient registry software market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global patient registry software market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Disease Type
1.1. Cancer
1.2. Cardiovascular Disorders
1.3. Diabetes
1.4. Rare or Orphan Disease
1.5. Others

2. Registry Type
2.1. Public Domain
2.2. Private Domain

3. End User
3.1. Government
3.2. Private

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. Dacima Software Inc.
5.2. Evado eClinical Solutions
5.3. Global Vision Technologies, Inc.
5.4. PatientCrossroads
5.5. Quintiles Inc.

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com